Investors
Listed on the Canadian Securities Exchange (CSE): COOL & OTC Markets (OTCQX): CLABF. Frankfurt: LD62, WKN: A2P8K3
Highlights
Delivery system
- Patented nanostrip technology
- Can further expand into other drugs
- $15MM + facility currently in production
R&D
- Patent pending technology
- One of few Health Canada Licesensed Dealer Labs
- API Grade
Clinics
- 200,000 + patients
- Clinical Trials
- Expansion to new locations
Opportunity
- Fully funded
- $20MM + invested capital
- New world-class management team
Trading Chart
Profile
| CUSIP | 21872J |
| ISIN | CA21872J2083 |
| Incorporated | BC / Dec 3 2019 |
| Fiscal Year End | Dec 31 |
| Industry | Junior industrial |
Filings
Consultants
Legal Counsel
Cassels
Auditor
Dale Matheson, Carr-Hilton Labonte LLP
Transfer Agent
Computershare Trust Company of Canada